CENTRAX Tablet Ref.[7513] Active ingredients: Prazepam

Source: Health Products Regulatory Authority (IE)  Revision Year: 2020  Publisher: Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24

Product name and form

Centrax 10mg Tablets.

Pharmaceutical Form

Tablet.

The tablet can be divided into equal doses.

Qualitative and quantitative composition

Each tablet contains 10mg prazepam.

Excipient with known effect: This medicine contains 93.73mg lactose monohydrate in each tablet.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Prazepam

Prazepam is a benzodiazepine derivative and has depressant effects on the central nervous system. Benzodiazepines act at the level of the limbic, thalamic, and hypothalamic regions of the CNS and can produce any level of CNS depression required including sedation, hypnosis, skeletal muscle relaxation, and anticonvulsant activity.
List of Excipients

Lactose monohydrate
Microcrystalline cellulose
Maize starch
Colloidal anhydrous silica
Magnesium stearate

Pack sizes and marketing

PVC/Aluminium blister pack of 60 tablets.

Marketing authorization holder

Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24

Marketing authorization dates and numbers

PA0822/010/001

Date of first authorisation: 7th July 1975
Date of last renewal: 3rd April 2010

Drugs

Drug Countries
CENTRAX Ireland
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈